Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

Sheba Medical Center

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Sudden Loss of Hearing

Treatments: Drug: prednisone - oral corticosteroid 1mg/kg/D for 1 week; Procedure: bed rest

Study type: Interventional

Funder types: Other

Identifiers

NCT00416143

SHEBA-06-4065-EC-CTIL

Details and patient eligibility

About

sudden sensorineural hearing loss:

• idiopathic in most cases
• 5-20/100,000 new cases annually in the U.S
• no establishes pathogenesis
• treated with oral steroids in most cases
• ~50% improvement in hearing levels
• bed rest - acceptable treatment, not well investigated

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with sudden sensorineural hearing loss

Exclusion criteria

• age less than 16 years
• contraindication for oral steroid treatment
• prior steroid treatment for hearing loss
• pregnent women

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)